ArticleBioMedicine2021

MicroRNA-26a-5p as a potential predictive factor for determining the effectiveness of trastuzumab therapy in HER-2 positive breast cancer patients.

Sadra Samavarchi Tehrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.